Pfinext Bioscience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 1 Year 4 Months
- Last Filing with ROC 31 Mar 2024
About Pfinext Bioscience
Pfinext Bioscience Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 October 2023 (One year and four months 6 days old ). Its registered office is in Sonipat, Haryana, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Kedia, Aman Kedia, Ankur Kajalia, and One other member serve as directors at the Company.
Company Details
- Location
Sonipat, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U46497HR2023PTC115930
- Company No.
115930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2023
- Date of AGM
21 Oct 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Who are the key members and board of directors at Pfinext Bioscience?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Kedia  | Director | 20-Oct-2023 | Current |
| Aman Kedia | Director | 20-Oct-2023 | Current |
| Ankur Kajalia | Director | 20-Oct-2023 | Current |
| Ankit Kedia | Director | 20-Oct-2023 | Current |
Financial Performance of Pfinext Bioscience.
Enhance accessibility to Pfinext Bioscience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pfinext Bioscience?
Unlock access to Pfinext Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pfinext Life Science Private LimitedAmit Kedia and Aman Kedia are mutual person
- Bioglen (India) Private Limited
Amit Kedia, Aman Kedia and 1 more are mutual person
- Pfinext Pharmaceutical Private Limited
Amit Kedia and Aman Kedia are mutual person
- Cellbond Exim India Private Limited
Ankur Kajalia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pfinext Bioscience?
Unlock and access historical data on people associated with Pfinext Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pfinext Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pfinext Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.